Fabrizio Cantini

9PUBLICATIONS
31CO-AUTHORS
Rheumatology and arthritisToxicology (incl. clinical toxicology)Cardiology (incl. cardiovascular diseases)NanomedicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 26, 2024
Secukinumab for the Treatment of Axial Spondyloarthritis: Long-Term Real-Life Data from Five Italian Referral Centers.

Stefano Gentileschi, Carlo CannistrĂ , Carla Gaggiano

|Feb 08, 2024
Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2 trials.

Fabrizio Cantini, Antonio Marchesoni, Lucia Novelli

|Oct 17, 2020
Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review.

Fabrizio Cantini, Delia Goletti, Linda Petrone

|Jun 20, 2020
Systematic review on tuberculosis risk in patients with rheumatoid arthritis receiving inhibitors of Janus Kinases.

Fabrizio Cantini, Corrado Blandizzi, Laura Niccoli

|May 06, 2020
Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data.

Maurizio Benucci, Arianna Damiani, Francesca Li Gobbi

Pageof 2